|
|
|
|
| Top Story |
| Advertisement |
Watch this brief video to learn how emerging technologies and virtual engagements like teledetailing and telepromotions can help you succeed in the evolving model for prescriber engagement.
 Learn more |
|
| Oncology |
|
|
Cancer's Disruptive Dozen |
The World Medical Innovation Forum presented its second list of breakthrough technologies—this time focused on oncology. Casey McDonald reports
... /Read more/ |
|
|
|
|
| Special Feature |
|
|
Pharm Exec's Top 50 Companies |
Pharm Exec's 16th annual listing of the top biopharma players may look placid on the surface, but, upon deeper inspection, does point to important transitions taking place in the larger business model
... /Read more/ |
|
|
| Europe |
|
|
Brexit and UK Pharma
|
Eleanor Biggs looks at the biggest uncertainties facing the pharma industry if the UK were to leave the European Union
... /Read more/ |
|
|
|
| Industry update |
| //VEXIM (Toulouse, France) appointed Sébastien Lemoine as VP International Sales and Market Development.//Almac Group (Craigavon, UK) appointed Kevin Reid to the position of Vice President of Corporate Marketing.//Primex Pharmaceuticals (Zug, Switzerland) announced the appointment of Alan Knox as Head of Global Marketing.// Adherium Limited (Melbourne, Australia) announced the establishment of Adherium North America, Inc., based in San Francisco, CA, and appointed James Hattersley as Senior Vice President of Business Development, North America.// |
|
|
|
| |
|
|
